The overall need/educational goal is to evaluate and incorporate new knowledge into clinical practice among palliative care and pain management pharmacists. The learning objectives support this goal.
This activity is developed to discuss a new route of administration for medical cannabis as it pertains to its use for pain management.
The disclosure policies of the SIUE School of Pharmacy Office of Continuing Professional Education requires all persons in a position to control content to disclose any relevant financial relationships with commercial interests. If a conflict is identified, the Office of Professional Continuing Education will initiate a process for resolving the conflict. The existence of relationships does not necessarily imply bias or lessen the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The persons required to disclose conflicts include all course faculty, the SIUE CPE administrator, all activity planners and all reviewers. The relevant commercial financial relationships or affiliations must have occured over the past 12 months.
The participant must provide the correct NABP ePID number/DOB combination in their electronic profile. All CPE evaluations must be completed within 60 days of activity. It is the participant's responsibility to check that their credit records are correct within the 60 day period after completion of the activity. Log in to CPE Monitor at www.mycpemonitor.net to view a list of all ACPE-accredited activities you have taken. Any discrepancies must be resolved with the CPE Provider directly and in a timely manner.
Requirements for CE Credit
To receive CE credit, you must view the entire presentation, complete the test questions with a minimum passing grade of 70%, and complete an evaluation of the activity.
CPE Credits will be submitted and posted to your NABP CPE profile within 2 weeks once you have successfully met these requirements.
This activity has a $10 fee. Members of the Society of Palliative Care Pharmacists should use their coupon code when registering to receive a discount. If you would like to join the Society, please visit their web site at: http://www.palliativepharmacist.org
To view the video, go to
To access the recorded course material, and view the discussion, go to:
The article for the review is also included in the Course materials.
- Describe the chemical components of cannabis and select pharmacokinetic and pharmacodynamic properties.
- Explain the process and product differences between inhaled (smoked) and vaporized routes of administration of cannabis.
- Identify the strengths and weaknesses of Wilsey et al s 2013 study evaluating vaporized cannabis in neuropathic pain.
Benjamin S. Kematick, Pharm.D.
Brief Bio : Dr. Kematick received his Pharm.D. from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences. He completed his PGY1 Residency at the University at Buffalo - Mobile Pharmacy Solution before proceeding to his current position as a PGY2 Resident in pain Management and Palliative Care. Dr. Kematick is a current member of the Society of Palliative Care Pharmacists.
Disclosure : Dr. Kematick has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.
Release Date: May 17, 2017
Credit Expiration Date: May 16, 2020